PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
17.22%
Revenue growth at 75-90% of NXPI's 19.27%. Bill Ackman would push for innovation or market expansion to catch up.
31.76%
Gross profit growth under 50% of NXPI's 73.12%. Michael Burry would be concerned about a severe competitive disadvantage.
80.61%
EBIT growth above 1.5x NXPI's 40.55%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
122.45%
Operating income growth above 1.5x NXPI's 40.55%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
106.92%
Net income growth above 1.5x NXPI's 16.76%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
104.76%
EPS growth above 1.5x NXPI's 16.87%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
110.00%
Diluted EPS growth above 1.5x NXPI's 16.27%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.95%
Share reduction while NXPI is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.31%
Reduced diluted shares while NXPI is at 0.55%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.23%
Dividend growth of 0.23% while NXPI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
49.73%
OCF growth at 50-75% of NXPI's 85.39%. Martin Whitman would question if the firm lags in monetizing sales effectively.
19.45%
FCF growth under 50% of NXPI's 83.54%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
61.72%
10Y CAGR of 61.72% while NXPI is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
22.16%
5Y CAGR of 22.16% while NXPI is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
-8.11%
Negative 3Y CAGR while NXPI stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
110.74%
OCF/share CAGR of 110.74% while NXPI is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
22.04%
OCF/share CAGR of 22.04% while NXPI is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
138.85%
3Y OCF/share CAGR of 138.85% while NXPI is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
79.23%
10Y net income/share CAGR of 79.23% while NXPI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
31.73%
Net income/share CAGR of 31.73% while NXPI is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
-8.03%
Negative 3Y CAGR while NXPI is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
59.53%
Equity/share CAGR of 59.53% while NXPI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
0.89%
Equity/share CAGR of 0.89% while NXPI is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
-5.83%
Negative 3Y equity/share growth while NXPI is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
460.05%
Dividend/share CAGR of 460.05% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
428.42%
Dividend/share CAGR of 428.42% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
260.00%
3Y dividend/share CAGR of 260.00% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
15.35%
AR growth of 15.35% while NXPI is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
4.99%
Inventory growth of 4.99% while NXPI is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
3.41%
Asset growth of 3.41% while NXPI is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
3.42%
BV/share growth of 3.42% while NXPI is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
No Data
No Data available this quarter, please select a different quarter.
-0.27%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
3.98%
SG&A declining or stable vs. NXPI's 8.52%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.